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Calcium-binding protein 1 (CaBP1), a calmodulin
(CaM) homolog, endows certain voltage-gated
calcium channels (CaVs) with unusual properties.
CaBP1 inhibits CaV1.2 calcium-dependent inactiva-
tion (CDI) and introduces calcium-dependent facilita-
tion (CDF). Here, we show that the ability of CaBP1 to
inhibit CaV1.2 CDI and induce CDF arises from inter-
action between the CaBP1 N-lobe and interlobe
linker residue Glu94. Unlike CaM, where functional
EF hands are essential for channel modulation,
CDI inhibition does not require functional CaBP1 EF
hands. Furthermore, CaBP1-mediated CDF has
different molecular requirements than CaM-medi-
ated CDF. Overall, the data show that CaBP1
comprises two structural modules having separate
functions: similar to CaM, the CaBP1 C-lobe serves
as a high-affinity anchor that binds the CaV1.2 IQ
domain at a site that overlaps with the Ca2+/CaM
C-lobe site, whereas the N-lobe/linker module
houses the elements required for channel modula-
tion. Discovery of this division provides the frame-
work for understanding how CaBP1 regulates CaVs.
INTRODUCTION
Voltage-gated calcium channels (CaVs) serve as a major source
of calcium influx in excitable cells (Catterall, 2000). Because
calcium ions are chemical messengers (Clapham, 2007), influx
through CaVs can directly link membrane potential charges to
stimulation of intracellular-signaling cascades (Catterall, 2000).
Although high-voltage activated CaVs consist of four essential
components (Van Petegem and Minor, 2006), i.e., a CaV1 or
CaV2 pore-forming CaVa1 (Catterall, 2000), a cytoplasmic CaVb
(Dolphin, 2003), CaVa2d (Davies et al., 2007), and calmodulin
(CaM) (Pitt, 2007), the composition of these large protein
complexes is not monolithic. In some contexts, such as cere-
bellar and hippocampal neurons (Lee et al., 2002; Zhou et al.,
2004), photoreceptor synapses (Haeseleer et al., 2004), andStructure 18, 1617–16auditory hair cells (Cui et al., 2007; Yang et al., 2006), members
from a family of calcium-binding proteins (CaBPs) homologous
to CaM (Haeseleer et al., 2000) can replace CaM. This compo-
nent exchange has profound effects on how CaVs respond to
calcium entry and results in channels that have strikingly different
functional properties than those modulated by CaM (Cui et al.,
2007; Few et al., 2005; Lautermilch et al., 2005; Lee et al.,
2002; Yang et al., 2006; Zhou et al., 2004, 2005).
When modulated by CaM, many CaV1s exhibit a strong
calcium-dependent inactivation (CDI) that limits calcium influx
during depolarization (Dunlap, 2007). In contrast, CaV1s under
the influence of CaBP1, a CaBP abundant in the brain and retina
(Haeseleer et al., 2000), have dramatically altered functional
properties. CaBP1 blocks CaV1.2 (Zhou et al., 2004, 2005) and
CaV1.3 (Cui et al., 2007; Yang et al., 2006) CDI and introduces
an increase in CaV1.2 (Zhou et al., 2004) peak current upon
repetitive stimulation, calcium-dependent facilitation (CDF).
These effects depend on displacement of CaM from the CaVa1
C-terminal IQ domain (Yang et al., 2006; Zhou et al., 2004),
a channel element that is critical for CaM-mediated CDI
(Erickson et al., 2003; Zu¨hlke et al., 1999).
As with many calcium-sensor proteins (Burgoyne et al., 2004;
Haeseleer et al., 2002; Weiss and Burgoyne, 2002), both CaBP1
and CaM comprise two lobes that bear a pair of EF-hand
calcium-binding motifs (Haeseleer et al., 2000). Beyond this
common architecture, there are a number of differences.
CaBP1 is myristoylated at its N terminus, has an N-lobe that is
largely insensitive to calcium (Kd > 100 mM) (Wingard et al.,
2005), and a longer interlobe linker. Apart from recent NMR
structures of individual CaBP1 lobes (Li et al., 2009), little is
known about the high-resolution structure of complete CaBPs
or the details of how they interact with CaVs. Thus, it has
remained uncertain which CaBP1 features contribute to the stark
functional differences that CaBP1 brings to CaV modulation.
We set out to answer this question with respect to CaV1.2 and
find that the key element is an interaction between the N-lobe
and an interlobe linker residue that is conserved among CaBP
family members. We further show that CaBP1 comprises two
structural modules having separate functions. The CaBP1
C-lobe shares both structural and functional similarity with the
CaM C-lobe and acts as a high-affinity anchor that binds the
CaV1.2 IQ domain at a site that overlaps with the Ca
2+/CaM
C-lobe binding site. In contrast, the N-lobe/linker module31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1617
Figure 1. CaBP1-CaM Chimeras Demon-
strate the Importance of the N-Lobe and
Interlobe Linker
(A) Structure-based alignment of CaBP1 andCaM.
TheN-lobe andC-lobe are shaded green and blue,
respectively. CaBP1 N-terminal myristoylation
segment and interlobe linker are indicated by the
yellow and orange bars, respectively. EF-hand
positions are indicated above the sequence
according to standard nomenclature (Gifford
et al., 2007). Secondary structure elements are
indicated. CaBP1 residues Y56 and E94 are high-
lighted in red.
(B) CaBP1-mediated CDI inhibition is unaffected
by myristoylation site mutants. Representative
normalized ICa traces at a test potential
of +20 mV for CaV1.2 expressed with CaVb2a and
CaBP1 myristoylation mutants G2A and D2–15
(gray), CaBP1 (orange), or CaM (blue).
(C) ti300 values for data from (B).
(D) Representative normalized ICa traces at a test
potential of +20 mV for CaV1.2 expressed with
CaVb2a and CaBP1-CaM chimeras (gray), wild-
type CaBP1 (orange), or CaM (blue). Icons show
the origin of the domain elements: CaBP1 (orange)
and CaM (blue). Chimeras containing the CaBP1
N-lobe all contain the myristoylation domain.
(E) ti300 values for data from (D).
(F) Relative current amplitude changes of ICa in
response to 40 +20 mV pulses delivered at 3 Hz
for CaV1.2 expressed with CaVb2a and the indi-
cated chimeras. First (black), last (red), and every
fourth trace (gray) are shown.
(G) Relative current changes between the last and
first pulse for CaV1.2 expressed with CaVb2a and
CaBP1, CaM, or the indicated chimeras. Paren-
theses indicate the number of oocytes tested.
Error bars show SD. See also Figures S1 and S2.
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CaBP1 Modulation of CaV1.2contains the elements required for the unique functional effects
CaBP1 has on CaV1.2. Delineation of these conserved CaBP
structural elements provides the required framework for under-
standing how this family of calcium-sensor proteins affects
CaVs and other target proteins in a manner distinct from CaM.
RESULTS
CaBP1 N-Lobe and Interlobe Linker Are Crucial for CDI
Inhibition
We used two-electrode voltage-clamp recording of Xenopus
oocytes to test whether CaBP1 N-terminal myristoylation1618 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltdw
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CaV1.2 because this lipid anchor is
important for CaBP1 modulation of
CaV2.1 (Few et al., 2005) and is an
obvious difference from CaM (Figure 1A).
Examination of calcium currents pro-
duced when CaV1.2 was co-expressed
with a CaBP1 G2A mutant (Few et al.,
2005) that blocks myristoylation (Rocque
et al., 1993) demonstrated that CaBP1
G2A could inhibit CDI as effectively asild-type CaBP1 (Figures 1B and 1C and Table 1). The enzyme
at carries out myristoylation is unable to process G2A
ubstrates and is conserved (Rocque et al., 1993). Nevertheless,
ensure that the N-terminal modification was eliminated, we
lso examined the consequences of deletion of the entire
aBP1 myristoylation site, CaBP1(D2-15). Similar to CaBP1
2A, CaBP1(D2–15) fully inhibited CDI (Figures 1B and 1C and
able 1). Thus, N-terminal myristoylation is not required for
aBP1 inhibition of CaV1.2 CDI.
Because CaBP1 (Li et al., 2009) and CaM (Masino et al., 2000;
salkova and Privalov, 1985) lobes fold independently, we de-
igned a set of CaBP1-CaM chimeras based on exchange of
Table 1. CaV1.2 Inactivation Parameters
ti300 (%) A1 (%) t1 (ms
1) A2 (%) t2 (ms
1) CDF40 N
CaM 68.7 ± 3.2 54.8 ± 5.3 26.2 ± 4.0 17.5 ± 4.4 131 ± 30 7.4 ± 3.4 8
CaBP1 7.4 ± 3.8 – – – – 8.8 ± 3.1 10
CaBP1 G2A 9.3 ± 5.3 – – – – 6.8 ± 6.4 6
CaBP1 D2–15 6.3 ± 3.1 – – – – 3.1 ± 3.8 6
CaBP1-CaM chimeras MMB 70.6 ± 5.1 56.1 ± 4.6 25.1 ± 2.8 18.8 ± 2.6 135 ± 28 6.7 ± 1.0 6
MBM 63.8 ± 5.1 49.0 ± 3.6 26.8 ± 2.6 18.7 ± 4.5 126 ± 13 7.0 ± 0.9 6
MBB 68.6 ± 4.1 55.6 ± 2.1 25.5 ± 2.1 16.8 ± 3.4 131 ± 17 8.4 ± 1.7 6
BMM 33.0 ± 13.3 41.6 ± 12.0 187 ± 41 – – 6.0 ± 1.7 9
BBM 0.3 ± 0.5 – – – – 22.4 ± 6.2 7
BMB 63.7 ± 11.8 43.8 ± 8.4 25.5 ± 2.2 26.8 ± 3.8 177 ± 42 18.6 ± 3.5 6
EF-hand mutants CaBP1 EF1 11.0 ± 5.2 – – – – 11.7 ± 8.4 6
CaBP1 EF3 23.2 ± 3.8 26.6 ± 6.3 152 ± 49 – – 3.4 ± 4.4 7
CaBP1 EF4 17.0 ± 5.9 21.0 ± 7.6 171 ± 56 – – 3.6 ± 3.3 9
CaBP1 EF34 17.8 ± 6.3 23.7 ± 4.9 181 ± 70 – – 0.4 ± 1.3 7
Interlobe-linker mutants CaBP1 AETA 70.0 ± 2.1 54.1 ± 2.6 29.2 ± 1.4 20.7 ± 1.3 171 ± 22 34.4 ± 9.2 6
CaBP1 DMIG 69.6 ± 6.5 51.3 ± 4.6 25.6 ± 3.2 25.5 ± 5.6 193 ± 45 27.6 ± 4.5 10
CaBP1 DTDSDTDS 61.7 ± 10.9 46.8 ± 8.2 24.2 ± 3.1 22.3 ± 5.8 203 ± 68 23.4 ± 4.1 6
CaBP1 4G 26.8 ± 5.1 25.4 ± 4.4 90.7 ± 44.7 – – 3.2 ± 4.4 7
CaBP1 8G 64.4 ± 6.2 51.1 ± 5.6 22.9 ± 2.5 18.6 ± 0.7 162 ± 17 27.5 ± 3.0 6
CaBP1 8A 71.6 ± 5.4 53.2 ± 4.5 21.5 ± 0.7 23.0 ± 3.6 131 ± 13 16.4 ± 2.2 6
CaBP1 E94A 62.7 ± 6.4 47.9 ± 5.1 25.0 ± 2.8 21.0 ± 2.5 183 ± 33 22.1 ± 3.6 6
CaBP1 E94Q 59.2 ± 4.9 40.9 ± 4.6 26.0 ± 3.8 26.1 ± 5.2 213 ± 32 16.9 ± 3.0 7
CaBP1 E94D 20.2 ± 2.8 19.7 ± 5.2 133 ± 69 – – 8.6 ± 5.9 8
CaBP1 T95A 24.5 ± 6.2 23.3 ± 6.6 88.9 ± 23.5 – – 6.6 ± 3.8 6
CaBP1 D97A 22.6 ± 4.1 19.7 ± 5.5 121 ± 56 – – 14.4 ± 2.3 6
CaBP1 M98A 17.8 ± 2.9 15.0 ± 2.9 64.0 ± 11.2 – – 5.1 ± 2.4 6
CaBP1 I99A 18.0 ± 2.9 18.1 ± 2.7 103 ± 23 – – 6.2 ± 2.9 6
CaBP1 G100A 22.6 ± 5.5 21.6 ± 5.8 41.5 ± 9.8 – – 8.2 ± 3.2 6
CaBP1 Y56A 41.9 ± 6.9 30.6 ± 4.6 24.9 ± 1.1 20.3 ± 4.8 280 ± 96 0.2 ± 5.5 6
CaBP1 K130A 7.2 ± 5.3 – – – – 6.8 ± 4.2 6
CaV1.2 TripleA, CaV b2a, CaBP1 3.9 ± 3.0 – – – – 6.7 ± 1.7 7
CaV1.2 HotA, CaV b2a, CaBP1 23.6 ± 8.4 29.1 ± 8.2 171 ± 65 – – 11.9 ± 4.0 6
CaV1.2, no CaVb, CaBP1 13.6 ± 6.3 22.3 ± 2.6 191 ± 22 – – 10.9 ± 4.1 6
CaV1.2 I1624A, CaVb2a, CaM 17.5 ± 11.3 18.1 ± 12.1 88.9 ± 9.7 – – 33.8 ± 10.8 6
CaV1.2 I1624A, CaVb2a, CaBP1 5.3 ± 2.8 – – – – 8.6 ± 2.3 8
Data are expressed as mean values ± standard deviation. All experiments correspond to the mean of at least two separate oocyte batches.
Structure
CaBP1 Modulation of CaV1.2three elements (N-lobe, interlobe linker, and C-lobe) and tested
their effects on CaV1.2 expressed in Xenopus oocytes. We
designate the chimeras with three letter names, e.g. MMB, in
which the first, second, and third positions denote the N-lobe, in-
terlobe linker, and C-lobe, respectively, and each letter denotes
the element origin: ‘‘M’’ for CaM, and ‘‘B’’ for CaBP1.
All CaM N-lobe chimeras (MMB, MBB, and MBM) lacked the
hallmark CaV1.2 CDI inhibition caused by CaBP1 and instead
supported CDI similar to CaM (Figures 1D and 1E and Table 1).
CaM interlobe linker chimeras (MMB, BMB, and BMM) also
allowed CDI to proceed. Notably, the chimera having the CaM
interlobe linker exchanged into CaBP1, BMB, failed to inhibit
CDI. Pull-down assays showed that all chimeras retained ability
to interact with the CaV1.2 IQ domain (see Figure S1 availableStructure 18, 1617–16online) and eliminate the possibility that the absence of CDI inhi-
bition arose from failure of the chimeras to fold properly and bind
the CaV1.2 IQ domain. Together, these results suggest that the
inability of MMB, MBB, MBM, MMB, BMB, and BMM to inhibit
CDI arises from the absence of elements in the CaBP1 N-lobe
(MBB, MBM, and MMB) and CaBP1 interlobe linker (MMB,
BMB, and BMM). In further support of this, we found that BBM,
which has the CaBP1 N-lobe and interlobe linker joined to the
CaM C-lobe, blocks CaV1.2 CDI, even more potently than
CaBP1 (Figures 1D and 1E). BBM additionally causes slower
CaV1.2 activation (Figure 1D). Taken together, the results from
the chimeras strongly suggest that the key elements underlying
the CaBP1 and CaM functional differences with respect to CDI
reside in the N-terminal lobe and interlobe linker.31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1619
Figure 2. Interlobe Linker Length and
Sequence Have a Crucial Role in CaBP1
Function
(A) Representative normalized ICa traces at a test
potential of +20 mV for CaV1.2 expressed with
CaVb2a and indicated CaBP1 linker mutants
(gray), CaBP1 (orange), or CaM (blue).
(B) ti300 values for data from (A). BMB values are
from Figure 1.
(C) Relative current amplitude changes of ICa and
IBa in response to 40 +20 mV pulses delivered at
3 Hz for CaV1.2 expressed with CaVb2a and
CaBP1, CaM, or the DMIG linker mutant. First
(black), last (red), and every fourth trace (gray)
are shown.
(D) Averaged frequency-dependent change of ICa
current amplitude for CaV1.2 expressed with
CaVb2a and CaBP1, CaM, or the indicated linker
mutants.
(E) Comparison of ICa recovery from inactivation
for CaV1.2 expressed with CaVb2a and CaM
(blue) or the CaBP1 DMIG linker mutant (orange)
in response to two 450ms pulses to +20 mV sepa-
rated by variable time intervals.
Parentheses indicate thenumberofoocytes tested.
Error bars show SD. See also Figures S1 and S2.
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CaBP1 Modulation of CaV1.2BesidesCDI inhibition, CaBP1 causesCaV1.2CDF (Zhou et al.,
2004) (Figure 1F). We tested whether the CaBP1-CaM chimeras
retained this property. Chimeras bearing either the CaM N-lobe
(MBB, MBM, and MMB) or CaM interlobe linker (MMB, BMB,
and BMM) were unable to support CaV1.2 CDF. Except for
BMB,which introduced a larger progressive loss in current ampli-
tude (Figures 1F and 1G), channels expressed with these
chimeras were indistinguishable from channels expressed with
CaM. In contrast, BBM caused CaV1.2 CDF that was 2-fold
stronger than that of CaBP1 (Figures 1F and 1G). Hence, BBM
embodies both main functional properties of CaBP1, the ability
to inhibit CaV1.2 CDI and the ability to confer CDF. Together,
the data indicate that the CaBP1 N-lobe and interlobe linker
bear the modulatory elements unique to CaBP1, whereas
CaBP1 and CaM C-terminal lobes perform similar functions.
CaBP1 Interlobe Linker Functional Properties
The CaBP1 and CaM interlobe linker lengths differ by four resi-
dues (Figure 1A), a divergence conserved among CaBPs1620 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltd All rights reservedI
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r(Haeseleer et al., 2000) (Figure S2). Given
the apparent importance of the interlobe
linker, we investigated whether its length,
composition, or both were crucial for
CaBP1 function. CaBP1 constructs
having an interlobe linker composed of
the first four (93–96, ‘‘AETA’’) or last four
interlobe linker residues (97–100,
‘‘DMIG’’) failed to inhibit CDI (Figures 2A
and 2B). Replacement of the CaBP1 in-
terlobe linker with a duplication of the
CaM interlobe linker (DTDSDTDS), octa-
alanine (8A), or octa-glycine (8G) also
failed to inhibit CDI (Figures 2A and 2B).Unexpectedly, the protocol used to induceCDF causedCaV1.2
todisplayastrong,calcium-dependent reduction incurrent ampli-
tude in the presence of all of the CaBP1 interlobe linker mutants
(Figure 2C). This phenomenon, which we term ‘‘CD
tachyphylaxis,’’ is stronger than the small current suppression
seen with CaM (Figure 2D) and provides evidence that the inter-
lobe linkermanipulationsdid not incapacitate theCaBP1mutants
This is corroborated by pull-down experiments that show that the
individual mutants retain the ability to bind the CaV1.2 IQ domain
(Figure S1B). Further analysis of the DMIG mutant showed tha
the CDI tachyphylaxis arises from changes in recovery from inac-
tivation (Figure 2E). Following a depolarization pulse, CaV1.2 co-
expressed with CaM shows essentially full recovery afte
750 ms. In contrast, 7% of CaV1.2 co-expressed with DMIG
fail to recover in the same period. Over longer interpulse periods
bothCaMandDMIGcontaining channels recover fully (Figure2E)
Taken together, the data from the chimeras and interlobe linke
mutants establish that both the length and composition the
CaBP1 interlobe linker are crucial for modulation of CaV1.2.
Structure
CaBP1 Modulation of CaV1.2N- and C-Lobes Contribute to CaBP1-CaV1.2 IQ Domain
Affinity
We turned to isothermal titration calorimetry (ITC) to investigate
howCaBP1 interacts with the CaV1.2 IQ domain, the domain that
is essential for CaBP1 CDI inhibition (Zhou et al., 2004). Experi-
ments using individual CaBP1 lobes in the presence of 1 mM
calcium, Ca2+/N-lobeBP and Ca
2+/C-lobeBP, revealed that each
has a single binding site on the CaV1.2 IQ domain (Figures 3A
and 3B and Table 2). Ca2+/N-lobeBP binding is an endothermic
reaction having modest affinity (Kd = 1.11 ± 0.08 mM), whereas
Ca2+/C-lobeBP binds 100-fold stronger via an exothermic
reaction that has an affinity (Kd = 10.5 ± 1.9 nM) similar to
Ca2+/C-lobeCaM (Van Petegem et al., 2005). Competition exper-
iments in which Ca2+/N-lobeBP was titrated into a preformed
Ca2+/C-lobeBP-CaV1.2 IQ domain complex demonstrate that
Ca2+/C-lobeBP prevents Ca
2+/N-lobeBP binding and indicate
that the binding sites overlap (Figure 3C). As expected from
the affinity differences, Ca2+/C-lobeBP can displace Ca
2+/
N-lobeBP from the CaV1.2 IQ domain (Figure 3D). The ability of
both Ca2+/CaBP1 lobes to bind the CaV1.2 IQ domain at an over-
lapping site is reminiscent of the behavior of individual Ca2+/CaM
lobes (Kim et al., 2008; Van Petegem et al., 2005).
Unlike the simple, individual lobe-binding isotherms, titration
of full-length Ca2+/CaBP1 into the CaV1.2 IQ domain showed
a V-shaped isotherm that could not be attributed to a single
binding event (Figure 3E). Because Ca2+/N-lobeBP and Ca
2+/
C-lobeBP bind to the CaV1.2 IQ domain in a competitive manner,
we wondered whether the complex isotherm arose from contri-
butions of each lobe. ITC experiments in which equimolar
portions of individual Ca2+/CaBP1 lobes were titrated into the
CaV1.2 IQ domain produced a binding isotherm very similar to
that of full-length Ca2+/CaBP1 (Figure 3F). Furthermore, when
we used parameters from the single-lobe experiments to simu-
late the isotherm in which Ca2+/N-lobeBP and Ca
2+/C-lobeBP
bind to a single, overlapping IQ domain site, we found excellent
correspondence to the measured isotherm (Figure 3F, red
triangles). These results indicate that the ‘‘V’’-shaped nature of
the isotherm represents a sequence of two events: (1) indepen-
dent binding of Ca2+/N-lobeBP and Ca
2+/C-lobeBP to separate
CaV1.2 IQ domains when the IQ domain is in excess, and (2)
replacement of Ca2+/N-lobeBP by Ca
2+/C-lobeBP as the IQ
domain becomes limiting. The ability to dissect the binding
reaction this way set the stage for an experiment to determine
the thermodynamics of the Ca2+/CaBP1- CaV1.2 IQ domain
interaction and test whether the ‘‘V’’-shaped isotherm observed
with full-length Ca2+/CaBP1 (Figure 3E) arose from a similar
course of events.
Titration ofCa2+/CaBP1 into preformedCa2+/N-lobeBP-CaV1.2
IQ domain complexes yielded a titration isotherm having a single
transition (Figure 3G). Analysis using competition ligand binding
by displacement (Sigurskjold, 2000) in the context of the thermo-
dynamic cycle in Figure 3H reveals that Ca2+/CaBP1 binds the
CaV1.2 IQ domain 40-fold stronger than measured for Ca2+/
C-lobeBP alone (Kd = 296 ± 70 pM) (Table 2). This increased
affinity is accompanied by a binding enthalpy increase that
indicates that Ca2+/N-lobeBP, the interlobe linker, or both
contribute to the binding reaction by interacting with the CaV1.2
IQ domain at sites separate from the Ca2+/C-lobeBP binding
site. Taken together, the ITC experiments establish that theStructure 18, 1617–16CaBP Ca2+/C-lobe interacts with the CaV1.2 IQ domain in
amanner similar to theCa2+/CaMC-lobe and show that elements
from the entire CaBP1 participate in CaV1.2 IQ domain binding.
Functional EF Hands Not Required for CDI Inhibition
CaBP1 has four EF hands; however, the importance of metal
binding to N-lobe EF hands is unclear. EF1 hasweakCa2+ affinity
(Wingard et al., 2005), and EF2 is nonfunctional due to the lack of
a canonical residue at the ‘‘z’’ position (Figure 1A) (Gifford et al.,
2007; Haeseleer et al., 2000). To test whether CaBP1 inhibition of
CaV1.2 CDI requires the ability of the CaBP1 EF hands to bind
metal ions, we examined the consequences of introduction of
a D/A mutation at the ‘‘x’’ position of each functional EF
hand. This mutation is analogous to those used to dissect CaM
EF-hand function (Peterson et al., 1999) and should reduce
metal-binding ability substantially. CaBP1 bearing a disrupted
EF1 was functionally indistinguishable from wild type (Figures
4A and 4B and Table 1). In contrast, EF3, EF4, and EF34 muta-
tions diminished but did not eliminate the ability of CaBP1 to
inhibit CaV1.2 CDI. Thus, the capacity of CaBP1C-lobe EF hands
to bindmetal ions is important but not essential for CDI inhibition.
This relative insensitivity to EF-hand disruption stands in contrast
to CaM, where functional C-lobe EF hands are required for CDI
(Alseikhan et al., 2002; Peterson et al., 1999). The effects of
CaBP1 EF34 are reminiscent of the ability of the CaM EF34
mutant to block CDI (Peterson et al., 1999) and suggest that
part of the CaBP1 mechanism may be competition with apo-
CaM. In contrast to the minor effects on CDI inhibition, the EF3
and EF4 mutants greatly diminished CaV1.2 CDF (Figures 4C
and 4D) and indicate that CaBP1-mediated CDF requires Ca2+
binding to the C-lobe.
CaBP1 Crystal Structure
To understand how the CaBP1 N-lobe and interlobe linker
contribute to function, we crystallized and determined the struc-
ture of the CaBP1 functional core, CaBP1(D2–15). CaBP1
(D2–15) crystallized in the I23 space group and diffracted
X-rays to 2.9 A˚ (Table 3). Surface-entropy reduction (Derewenda
and Vekilov, 2006) identified a mutant, CaBP1(D2–15) K130A,
that did not alter function (Table 1), gave crystals having
a different space group, P3121 and improved resolution, 2.4 A˚,
and that enabled solution by MAD (Hendrickson and Ogata,
1997) using selenomethionine-substituted protein. The 2.4 A˚
structure was used for molecular replacement of the I23 crystal
form. Because there were no major differences between the
structures, we used chain A from the 2.4 A˚ structure for analysis.
CaBP1 has four EF hands arranged into two lobes. Unexpect-
edly, a well-ordered interlobe linker (residues 93–100) connects
the lobes (Figure 5A). N-lobe EF hands, EF1 and EF2, lack
ligands; whereas C-lobe EF hands, EF3 and EF4, each contain
a calcium ion. The compact structure is different from what
has been observed by NMR, which found independent lobes
and a disordered interlobe linker (Li et al., 2009). Comparison
with crystal structures of compact (Fallon and Quiocho, 2003)
and extended (Wilson and Brunger, 2000) Ca2+/CaM con-
formations reveals that the CaBP1 lobe orientation is different
from both (Figure S3A). Despite the compact conformation, the
CaBP1 lobes make few contacts with each other and bury
only 270 A˚2.31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1621
Figure 3. Characterization of Ca2+/CaBP1-CaV1.2 IQ Domain Interactions
(A–G) Exemplar ITC titrations for: (A) 75 mMCa2+/N-lobeBP into 7.5 mM IQ domain; (B) 75 mMCa
2+/C-lobeBP into 7.5 mM IQ domain; (C) 75 mMCa
2+/N-lobeBP into
7.5 mM CaV1.2 IQ domain and 11.25 mM Ca
2+/C-lobeBP; (D) 75 mM Ca
2+/C-lobeBP into 7.5 mM IQ domain and 50 mM Ca
2+/N-lobeBP; (E) 75 mM Ca
2+/CaBP1 into
5.5 mM IQ domain; (F) 75 mMCa2+/C-lobeBP and 75 mMCa
2+/N-lobeBP into 7.5 mM IQ domain (red triangles denote estimates of enthalpy changes using binding
parameters derived from the single-lobe binding.); and (G) 75 mM Ca2+/CaBP1 into 7.5 mM IQ domain and 50 mM Ca2+/N-lobeBP.
(H) Thermodynamic cycle for analysis of the binding of CaBP1 (Ka3) to theCaV1.2 IQ domain. Ka1 describesCa
2+/N-lobeBp binding. Ka2 describes the competition
of Ca2+/N-lobeBP by CaBP1. Cartoons depict the observed binding reactions.
Structure
CaBP1 Modulation of CaV1.2TheN-lobe is in the calcium-free apo-form.Neither EF1 nor EF2
has electron density indicative of a metal ion, despite crystalliza-
tion conditions containingmillimolar Ca2+. The apo-N-lobe shows1622 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltda number of differences from theMg2+-boundN-lobe NMR struc-
ture (Li et al., 2009) (rmsdCa = 2.5 A˚). Themost notable is in the E1
helix (Figure 5B). In the apo-form, E1 extends by an extra turn thatAll rights reserved
Table 2. Titration Calorimetry Data
Cell Syringe T (C) N Kd (nM) N DH (kcal mol
1) DS (cal mol1 K1) Ka/Ka (wt) DDG(kcal mol
1)
CaV1.2 IQ Ca
2+/N-lobeBP 15 0.82 ± 0.05 1100 ± 80 3 2.09 ± 0.40 34.5 ± 1.5 – –
Ca2+/C-lobeBP 15 0.90 ± 0.07 10.5 ± 1.9 4 2.88 ± 0.19 26.5 ± 0.6 – –
Ca2+/C-lobeBP 25 0.98 ± 0.11 15.0 ± 0.7 2 8.63 ± 0.24 6.9 ± 0.9 – –
Ca2+/C-lobeCaM
a 15 0.98 ± 0.18 2.63 ± 0.07 2 6.77 ± 0.24 15.75 ± 0.78 – –
CaV1.2 IQ
Ca2+/N-lobe
Ca2+/C-lobeBP 15 0.96 ± 0.01 16.6 ± 0.7 2 3.17 ± 0.05 24.1 ± 0.7 – –
Ca2+/CaBP1 15 0.93 ± 0.12 0.288 ± 0.070 2 4.72 ± 0.07 26.6 ± 0.7 – –
Ca2+/CaBP1 E94A 15 1.04 ± 0.04 0.336 ± 0.097 2 7.75 ± 0.31 15.9 ± 0.5 0.86 ± 0.32 0.06 ± 0.22
CaV1.2 IQ F1628A Ca
2+/C-lobeBP 25 0.88 ± 0.03 727 ± 224 2 4.87 ± 0.11 11.8 ± 1.0 0.021 ± 0.006 2.25 ± 0.18
CaV1.2 IQ F1631A Ca
2+/C-lobeBP 15 0.83 ± 0.03 345 ± 107 2 2.22 ± 0.20 21.9 ± 1.3 0.030 ± 0.011 1.82 ± 0.21
Ca2+/C-lobeCaM 15 0.80 ± 0.03 17.3 ± 4.3 2 4.87 ± 0.08 18.7 ± 0.8 0.152 ± 0.038 1.22 ± 0.14
Data are expressed as mean values ± standard deviation. DDG is calculated with respect to the wild-type lobe or protein at 15Cwith the exception of
data for F1628A, which are calculated at 25C.
a Values from Van Petegem et al. (2005). See also Figure S5.
Structure
CaBP1 Modulation of CaV1.2encompasses the ‘‘x’’ and ‘‘y’’ ligand-binding residues,Asp35and
Asp37, and clasheswith themetal ion position in theMg2+-bound
structure (Li et al., 2009) (Figure 5B). Additionally, apo-N-lobe EF1
and EF2 are further away from each other and lack the short b-
hairpin that connects them in the Mg2+-bound structure (Fig-
ure 5B). These differences indicate that conformational changes,
particularly in EF1, accompany metal binding and are consistent
with divalent ion-induced chemical shift changes (Wingard et al.,
2005). Although there are some differences in packing, the
N-lobe hydrophobic core is buried in both forms (Figure S3B)
and does not undergo large changes in exposure seen in the
classic apo/Ca2+/CaM transition (Gifford et al., 2007; Grabarek,
2006) or in the CaBP1 apo/Ca2+/C-lobe transition (Li et al.,
2009). The lack of large divalent ion-induced conformational
changes agrees with the absence of EF1 D/A functional effects
(Figures 4A and 4B) and suggests that N-lobe metal binding is
unnecessary for CaBP1-mediated CaV1.2 modulation.
The CaBP1 Ca2+/C-lobe is similar to the NMR structure
(rmsdCa = 1.3 A˚ over 60 Ca positions) (Figure 5C) and resembles
the Ca2+/CaM C-lobe ‘‘open’’ conformation. The structural simi-
larity is even better when compared to Ca2+/CaM crystal struc-
tures, regardless of whether the comparison is made with the
Ca2+/CaM C-lobe alone (Wilson and Brunger, 2000) or bound
to a target such as the CaV1.2 IQ domain (Van Petegem et al.,
2005), (RMSDCa = 1.0 A˚ over 60 Ca positions for each) (Fig-
ure 5D). This similarity extends to many of the hydrophobic
pocket side chains. Consequently, the CaBP1 Ca2+/C-lobe
hydrophobic pocket appears ready to engage the CaV1.2 IQ
domain in a manner similar to the CaM Ca2+/C-lobe (Van Pete-
gem et al., 2005).
Themost striking aspect of the structure is thewell-ordered in-
terlobe linker (Figures 5A; Figure S3C), which is clamped to the
N-lobe by insertion of Glu94 into a largely hydrophobic N-lobe
cleft lined by Tyr56 and Leu91 (Figure 5E). This interaction is
absent from the NMR structure (Li et al., 2009). Within the
N-lobe cleft, the Glu94 side chain is within hydrogen bonding
distance of the Met54 backbone carbonyl oxygen. Comparison
of non-crystallographically related asymmetric unit monomers
reveals that the single helical turn in the C-terminal half of the
linker (residues 95–99) forms a hinge point for a 5 rotationStructure 18, 1617–16between the lobes (Figure S3D) and indicates that even in the
compact state, there is flexibility between the lobes.
Ca2+/C-LobeBP and Ca
2+/C-LobeCaM-IQ Domain Binding
Sites Overlap
MMB and BBM chimeras having swapped CaBP1 and CaM
C-lobes retain the properties of the parent, suggesting that
CaBP1 and CaM C-lobes are functionally interchangeable (Fig-
ure 1). This, together with the strong structural similarity between
Ca2+/C-lobeBP and Ca
2+/C-lobeCaM bound to the CaV1.2 IQ
domain (Figure 5D) and the prior evidence that CaBP1 acts by
competing with CaM for the IQ domain (Zhou et al., 2004), led us
to wonder whether CaBP1 and CaM Ca2+/C-lobes interact with
theCaV1.2 IQdomainat a commonsite. TitrationofCa
2+/C-lobeBP
into a preformed Ca2+/C-lobeCaM-CaV1.2 IQ domain complex
shows that Ca2+/C-lobeCaM blocks binding of Ca
2+/C-lobeBP (Fig-
ure 6A) and supports the idea that the high-affinity CaV1.2 IQ
domain binding sites for each overlap. To explore this possibility
further, we examined the effects of alanine mutations at F1628
and F1631, two residues that serve as anchors for Ca2+/C-lobe-
CaM-CaV1.2 IQ domain interactions (Van Petegem et al., 2005).
ITC experiments with Ca2+/C-lobeBP and the F1628A peptide
at 15C, the temperature of our other ITC analyses, gave a small,
endothermic signal (Figure 6B). Therefore, we evaluated Ca2+/
C-lobeBP binding to the F1628A peptide at 25
C, where the
signal was robust (Figure 6C) and compared the results to titra-
tion of Ca2+/C-lobeBP into the wild-type peptide at the same
temperature (Figure 6D). The data show that CaV1.2 F1628A
reduced Ca2+/C-lobeBP affinity and binding enthalpy by 48-
fold and 4 kcal mol1, respectively. The enthalpy reduction
magnitude is similar to that caused by F1628A for Ca2+/
C-lobeCaM (Van Petegem et al., 2005) and is consistent with
a loss of hydrophobic interactions. Measurements with the
F1631A peptide (Figure 6E) showed an 33-fold and 0.6 kcal
mol1 reduction in affinity and binding enthalpy, respectively.
The F1631A change also reduces binding affinity and enthalpy
for Ca2+/C-lobeCaM (Figure 6F). Taken together, these experi-
ments strongly support the idea that the CaBP1 Ca2+/C-lobe
interacts with the CaV1.2 IQ domain in a manner akin to the
Ca2+/CaM C-lobe (Fallon et al., 2005; Van Petegem et al., 2005).31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1623
Figure 4. C-Terminal EF Hands Are
Required for CaBP1-Mediated CDF, but
Not for Inhibition of CDI
(A) Representative normalized ICa traces at a test
potential of +20 mV for CaV1.2 expressed with
CaVb2a and indicated CaBP1 EF-hand mutants
(gray), CaBP1 (orange), or CaM (blue).
(B) ti300 values for data from (A).
(C) Relative current amplitude changes of ICa in
response to 40 +20 mV pulses delivered at 3 Hz
for CaV1.2 expressed with CaVb2a and the indi-
cated CaBP1 EF-hand mutants, CaBP1, or CaM.
(D) Averaged frequency-dependent change of ICa
current amplitude for CaV1.2 expressed with
CaVb2a and the indicated CaBP1 EF-hand
mutants, CaBP1, or CaM. Parentheses indicate
the number of oocytes tested.
Error bars represent SD. P values with respect to
wild type were calculated using Student’s t test:
N.S., not significant; p > 0.05; ***p < 0.005.
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CaBP1 Modulation of CaV1.2Interlobe Linker Glu94 Is Essential for CDI Inhibition but
Not CaV1.2 IQ Domain Binding
Given that the CaBP1 interlobe linker is well ordered, makes
specific interactions with the N-lobe, and is crucial to CDI inhibi-
tion, we used an alanine scan to investigate the functional contri-
bution of each residue. Each alanine mutation diminished CDI
inhibition (Figures 7A and 7B); however, E94A was the only
change that completely eliminated CDI inhibition (Figures 7A
and 7B). E94A also caused the appearance of CDI tachyphylaxis
(Figures 7C and 7D) resulting from changes in recovery from
inactivation similar to the DMIG linker mutant (Figure S4).
To explore the importance of the Glu94 position further, we
tested the effects of E94Q and E94D. E94Q almost completely
eliminated CDI inhibition (Figures 7A and 7B), whereas E94D al-
lowed partial CDI inhibition. These results indicate that the side
chain carboxylate and precise side chain geometry are essential.
To probe the N-lobe/Glu94 interaction further, we replaced
Tyr56, which contributes many N-lobe pocket/Glu94 contacts,1624 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltda
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diminishes CDI inhibition (Figure 7E and
Table 1) and further supports the impor-
tance of the N-lobe/Glu94 interaction.
The paramount functional role for Glu94
agrees well with the structurally defined
N-lobe/Glu94 interaction (Figure 5E).
Despite the effects that E94A had on
function, ITC experiments revealed that
the loss of the N-lobe/Glu94 interaction
caused by E94A altered DH and DS but
spared theaffinity for theCaV1.2 IQdomain
(Kd=0.336±0.097nM) (Table2;FigureS5).
This result promptedus to testwhether the
ordered nature of the linker was a key
element of CaBP1 function. We made
a mutant (4G) that maintained the N-lobe/
Glu94 interaction but that converted the
C-terminal half of the linker (residues 97–
100) to polyglycine. In contrast to the
devastating effect of E94A, 4G retainedn ability to inhibit CDI that was on par with the single alanine
utants (Figure7F). Thus, althoughboth theGlu94/N-lobe interac-
on and interlobe linker length (Figure 2) are essential for CaBP1
nction, the order seen in the C-terminal half of the linker is not.
aBP1 and CaM-Mediated CDF Are Two Distinct
rocesses
aM-mediated CaV1.2 CDF requires CaVb (Findeisen and Minor,
009; Grueter et al., 2006; Hudmon et al., 2005) and CaMKII
nderson et al., 1994; Grueter et al., 2006; Hudmon et al., 2005;
uan and Bers, 1994). Although CaMKII activation is not neces-
ary for CaBP1-mediated CDF (Zhou et al., 2004), the extent to
hich CaV1.2 CaM-mediated CDF (Van Petegem et al., 2005;
u¨hlke et al., 1999, 2000) and CaBP1-mediated CDF (Zhou
t al., 2004) share molecular requirements has remained unclear.
o test whetherCaBP1-mediatedCDFnecessitates the presence
f CaVb, we used aCaV1.2mutant, ‘‘HotA,’’ that cannot bindCaVb
an Petegem et al., 2008) and that eliminates CaM-mediated
Table 3. Crystallographic Data Collection and Refinement Statistics
CaBP1 CaBP1 K130A
Data collection Native SeMet
Space group I23 P3121 P3121
Cell dimensions a/b/c (A˚) 206, 206, 206 69, 69, 344 69, 69, 345
a/b/g () 90, 90, 90 90, 90, 120 90, 90, 120
Resolution (A˚) 50-2.9
(3.06 – 2.90)
50 - 2.4
(2.53 - 2.40)
50-2.9
(3.06 – 2.90)
Peak Inflection Remote
Wavelength 1.11587 1.11587 0.97958 0.97972 1.01987
Rsym (%) 9.5 (45.1) 7.2 (43.2) 9.0 (38.2) 8.5 (34.9) 7.9 (28.6)
I/sI 6.4 (1.6) 7.1 (1.6) 6.7 (1.8) 6.9 (2.0) 7.2 (2.4)
Completeness (%) 97.5
(96.2)
99.4
(99.0)
100.0 (100.0) 100.0 (100.0) 99.9 (100.0)
Redundancy 4.0 (2.1) 3.9 (2.8) 6.9 (7.2) 6.9 (7.2) 6.9 (7.2)
Unique reflections 32321 43362
Average B-factor 99.7 54.4
Refinement
Rwork/Rfree (%) 21.3/25.0 25.2/29.5
No. of chains in AU 6 6
No. of protein atoms 7093 6835
No. of ligand atoms 12 42
Rmsd bond lengths (A˚) 0.020 0.016
Rmsd angles () 1.697 1.556
Ramachandran best/disallowed regions (%) 94.9/0.0 96.1/0.0
One crystal was used for each dataset. Values in parentheses are for highest-resolution shell.
Structure
CaBP1 Modulation of CaV1.2CDF (Findeisen and Minor, 2009). Unlike the case with CaM,
CaBP1 supports CDF when co-expressed with CaV1.2 HotA or
wild-type CaV1.2 in the absence of CaVb2a (Figures 8A and 8B).
Thus, CaBP1-mediated CDF does not require CaVb.
CaV1.2 CaM-mediated CDF is unmasked by the CaV1.2 IQ
domain mutation, I1624A (Van Petegem et al., 2005; Zu¨hlke
et al., 1999, 2000) (Figures 8A and 8B). If CaBP1-mediated CDFs
were similar to CaM-mediated CDFs, one might expect that
I1624A would enhance CaBP1-mediated CDF. Contrary to this
expectation, co-expression of CaV1.2 I1624A with CaBP1
produces CDF having a magnitude indistinguishable from that
seen with CaBP1 and CaV1.2 (Figures 8A and 8B). CaV1.2 IQ
domain residues F1618, Y1619, and F1622 are involved in Ca2+/
CaM N-lobe-IQ domain interactions that play a role in CaV1.2
CaM-mediated CDF (Hudmon et al., 2005; Van Petegem et al.,
2008). The triple alanine mutant, F1618A/Y1619A/F1622A
(‘‘TripleA’’), eliminates CaM-mediated CDF (Van Petegem et al.,
2008). In contrast, TripleA had no effect on CaBP1-mediated
CDF (Figures 8A and 8B) or on CaBP1 CDI inhibition (Figure 8C).
The insensitivity of CaBP1-mediated CDF to manipulations that
affect CaM-mediated CDF demonstrates that CaV1.2 CaM-medi-
atedCDFandCaV1.2CaBP1-mediatedCDFaredifferent and indi-
cates that their underlying molecular mechanisms are different.
DISCUSSION
CaBPs belong to a large calcium-sensor family found throughout
the nervous system (Burgoyne et al., 2004; Haeseleer et al.,Structure 18, 1617–162002; Weiss and Burgoyne, 2002) and closely resemble CaM
(Haeseleer et al., 2002;Weiss and Burgoyne, 2002). Accordingly,
CaBPs interact with diverse classes of CaM-modulated proteins
(Haynes et al., 2006): CaVs (Lee et al., 2002, Yang et al., 2002;
Zhou et al., 2004), IP3 receptors (Kasri et al., 2004; White et al.,
2006; Yang et al., 2002), TRP channels (Kinoshita-Kawada
et al., 2005), and myosin 1c (Tang et al., 2007). CaBP-target
interactions impart functional changes distinct from those
caused by CaM (Kasri et al., 2004; Lee et al., 2002; Yang et al.,
2002; Zhou et al., 2004) and may diversify neuronal responses
to calcium signals. CaBPs interact with and reshape the func-
tional properties of certain CaVs (Cui et al., 2007; Haeseleer
et al., 2004; Lee et al., 2002; Tippens and Lee, 2007; Yang
et al., 2006; Zhou et al., 2004). Because CaVs are prominent in
cellular calcium-signaling pathways (Clapham, 2007), CaBP re-
modeling of the CaV activity should reach well beyond electrical
excitation properties.
CDI is an important type of CaV feedback modulation that
limits cellular calcium entry in response to electrical activity.
There are a number of situations in which CDI is overridden
(Striessnig, 2007). One mechanism is CaBP1 substitution for
CaM within CaV multiprotein complexes in retinal (Haeseleer
et al., 2004) and auditory (Cui et al., 2007; Yang et al., 2006)
neurons. This component change also happens in the brain
(Zhou et al., 2004), blocks CDI in CaV1.2 and CaV1.3 (Cui et al.,
2007; Yang et al., 2006; Zhou et al., 2004, 2005), and introduces
CDF to CaV1.2 (Zhou et al., 2004). CaBP1 and CaM have two
independently folded EF hand-containing lobes separated by31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1625
Figure 5. Structure of CaBP1
(A) Cartoon representation of CaBP1. The N-lobe
(green), linker (red), and C-lobe (blue) are indi-
cated. Calcium ions are depicted as yellow
spheres. Secondary structure elements are
labeled.
(B) Superposition of CaBP1 apo-N-lobe structure
determined by X-ray (green) and Mg2+-bound
form determined by NMR (2K7B) (Li et al., 2009)
(light green). Mg2+ ion is a yellow sphere. B sheet
from the Mg2+-bound form is shown (salmon)
and labeled. Equivalent residues in the apo-lobe
structure are highlighted in red.
(C) Superposition of the CaBP1 Ca2+/C-lobe
structure determined by X-ray (blue) and NMR
(gray).
(D) Superposition of the CaBP1 Ca2+/C-lobe (dark
blue) and CaM Ca2+/C-lobe (marine) (1EXR) (Van
Petegem et al., 2005). Hydrophobic residues
involved in CaM Ca2+/C-lobe-IQ domain binding
and their CaBP1 Ca2+/C-lobe counterparts are
shown as sticks. (E) Details of the Glu94/N-lobe
cleft interaction. Glu94 and residues from the
N-lobe are shown as sticks. The N-lobe is colored
green and shown in surface representation. The
linker is indicated in red. E94 is shown in salmon.
Hydrogen-bond interaction between E94 and the
backbone carbonyls of Met54 is shown as black
dashes.
See also Figure S3.
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CaBP1 Modulation of CaV1.2a linker (Li et al., 2009;Masino et al., 2000; Tsalkova and Privalov,
1985). This likeness presents the question of which elements
endow CaBP1 with the ability to alter CaV1.2 behavior differently
from CaM. Our chimera-based analysis eliminated a role for
CaBP1 N-terminal myristoylation, which is important for CaV2.1
modulation (Few et al., 2005), and identified the N-lobe and inter-
lobe linker as the elements that allow CaBP1 to inhibit CDI and
enable CDF in CaV1.2 (Figure 1).
The ability of the CaBP1 C-lobe to bind calcium was important
but not integral to CDI inhibition. This lack of sensitivity would
seem to conflict with the reported calcium dependency of the
CaBP1-CaV1.2 IQ domain interaction (Zhou et al., 2004).
However, the ability of CaBP1-EF3, EF4, and EF34 mutants to
block CDI is reminiscent of the ability of the CaM EF34 mutant
to block CDI (Peterson et al., 1999) and suggests that part of
the CaBP1 CDI inhibition mechanism could arise from simple
competition with apo-CaM binding to CaV1.2. Nevertheless,
this effect cannot embody the entire mechanism. Our data
show that only the BBM chimera but not BMM or MBM
chimeras or the E94A mutant block CDI. If competition were
the only effect, these mutants would be potent CDI inhibitors.
Thus, the data strongly suggest that besides CaM competition,
there must be an active role for the CaBP1 N-lobe/Glu941626 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltd All rights reservedmodule in CaV1.2 CDI inhibition and this
role is the dominant contributor.
The CaBP1 crystal structure revealed
an unanticipated N-lobe/Glu94 interac-
tion (Figure 5E) that is indispensable for
CaBP1 CDI inhibition and CaBP1-medi-
ated CDF of CaV1.2 (Figure 7). It isnotable that this position is conserved in CaBP2, CaBP4, and
CaBP5 (Figure S2), particularly because CaBP4 inhibits CaV1.3
CDI (Cui et al., 2007; Yang et al., 2006). Thus, in addition to
serving as part of the CaBP1 module required for CaV1.2 CDI
inhibition, the N-lobe/Glu94 interaction may have a role in other
CaBPs.
The CaV1.2 IQ domain is the essential CaM modulation site
(Peterson et al., 1999; Pitt et al., 2001) and main CaBP1 binding
site (Zhou et al., 2004). Our data uncover a strong structural simi-
larity between the CaM and CaBP1 Ca2+/C-lobes (Figure 5D).
This structural mimicry suggests that both bind the CaV1.2 IQ
domain in a similar manner. This idea is supported by the inter-
changeability of CaBP1 and CaM C-lobes with respect to parent
molecule CaV1.2 modulation (Figures 1D–1G) and is consistent
with the similar functional sensitivity of both proteins to CaV1.2
IQ domain mutations (Zhou et al., 2004). Furthermore, our ITC
studies reveal that Ca2+/C-lobeBP and Ca
2+/C-lobeCaM bind
with similar affinities to a mutually exclusive CaV1.2 IQ domain
site (Figures 6A, 6C, and 6D and Table 2) and that mutations of
residues that form anchors for Ca2+/C-lobeCaM greatly diminish
the ability of Ca2+/C-lobeBP to bind (Figures 6C–6F). Together,
these results suggest that CaBP1 and CaM C-terminal lobes
have the same main function, formation of high-affinity
Figure 6. Ca2+/C-LobeBP and Ca
2+/C-LobeCaM Binding Sites Overlap on the CaV1.2 IQ Domain
Exemplar ITC titrations for: (A) 75 mMCa2+/C-lobeBP into a solution of 7.5 mM IQ domain and 11.25 mMCa
2+/C-lobeCaM; (B) 75 mMCa
2+/C-lobeBP into 7.5 mM IQ
domain F1628Amutant, 15C; (C) 75 mMCa2+/C-lobeBP into 7.5 mM IQ domain F1628Amutant, 25C; (D) 75 mMCa
2+/C-lobeBP into wild-type IQ domain, 25
C; (E)
75 mMCa2+/C-lobeBP into 7.5 mM IQ domain F1631Amutant; and (F) 75 mMCa
2+/C-lobeCaM into 7.5 mM IQ domain F1631Amutant. Cartoons depict the observed
binding modes for Ca2+/C-lobeBP (dark blue) and Ca
2+/C-lobeCaM (light blue). Stars indicate mutant IQ domains.
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CaBP1 Modulation of CaV1.2attachment to the CaV1.2 IQ domain and that this attachment
site overlaps.
ITC experiments with full-length CaBP1 show that it binds the
CaV1.2 IQ domain 40-fold stronger than Ca2+/C-lobeBP and
that the CaBP1 E94A mutation, which eliminates CDI inhibition,
has no effect on binding affinity. Superposition of the Ca2+/
CaBP1 and Ca2+/CaM C-lobes in the context of the Ca2+/
CaM-CaV1.2 IQ domain complex (Van Petegem et al., 2005) indi-
cates that the compact CaBP1 conformation observed in the
crystal structure is incompatible with CaV1.2 IQ domain binding.
Many CaBP1 N-lobe/Glu94 atoms clash with the CaV1.2 IQ helix
(Figure S6). Therefore, although there is good evidence that the
Ca2+/CaBP1 C-lobe binds the CaV1.2 IQ domain in a mode
similar to Ca2+/CaM C-lobe, CaBP1 binding must involve
a conformation in which the CaBP1 N-lobe is in a different posi-
tion than seen in the CaBP1 structure.Structure 18, 1617–16Our ITC experiments indicate that the CaBP1 N-lobe partici-
pates in CaV1.2 IQ domain binding. If the CaBP1 Ca
2+/C-lobe
and CaM Ca2+/C-lobe bind the CaV1.2 IQ domain similarly, one
candidate CaBP1 N-lobe interaction site would be the CaV1.2
IQ domain residues that comprise the CaM Ca2+/N-lobe
binding site (F1618, Y1619, and F1622) (Fallon et al., 2005; Van
Petegem et al., 2005). Nevertheless, functional analysis of the
CaV1.2 TripleA mutant, which disrupts these anchors and
eliminates CaM-mediated CDF (Van Petegem et al., 2005),
reveals that neither CaBP1-mediated CDF nor CDI inhibition
depends on these residues. Therefore, the CaBP1 N-lobe must
interact with CaV1.2 differently than the Ca
2+/CaM N-lobe.
Conformational differences between the CaBP1 crystal and
solution structures (Li et al., 2009) show that CaBP1 can
adopt various interlobe conformations. Furthermore, CaBP1
modulation of CaV1.2 tolerates substitutions that render the31, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1627
Figure 7. Functional Examination of the
CaBP1 Interlobe Linker and E94/N-Lobe
Interaction
(A) Representative normalized ICa traces at a test
potential of +20 mV for CaV1.2 expressed with
CaVb2a and indicated CaBP1 linker mutants
(gray), CaBP1 (orange), or CaM (blue).
(B) ti300 values for data from (A).
(C) Relative current changes between the last and
first pulse for CaV1.2 expressed with CaVb2a and
CaBP1, CaM, or the indicated mutants.
(D) Averaged frequency-dependent change of ICa
amplitude for (C).
(E and F) Representative normalized ICa traces at
a test potential of +20 mV for CaV1.2 expressed
with CaVb2a and indicated CaBP1 mutants (gray),
CaBP1 (orange), or CaM (blue). Graphs compare
ti300 values. Parentheses indicate the number of
oocytes tested.
Error bars show SD. See also Figures S4 and S6.
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CaBP1 Modulation of CaV1.2C-terminal part of the interlobe linker maximally flexible (Fig-
ure 7F). Thus, we propose that CaBP1 binds the CaV1.2 IQ
domain using a similar C-lobe position to CaM but an alternate
N-lobe pose such as an open structure that would maintain the
CaBP1 N-lobe/Glu94 interaction but flex in the C-terminal
portion of the interlobe linker. This could allow CaBP1 to interact
with the CaV1.2 cytoplasmic N-terminal domain, a channel
element that has the capacity to bind CaBP1 and that is required
for CaBP1 modulation of CaV1.2 (Zhou et al., 2005).
CaBP1 affects CaV1s and CaV2s differently. CaBP1 inhibits
CaV1.2 and CaV1.3 CDI (Cui et al., 2007; Yang et al., 2006;
Zhou et al., 2004, 2005), whereas it accelerates CaV2.1 CDI
and changes activation (Few et al., 2005; Lee et al., 2002). Addi-
tionally, CaBP1 blocks CaV2.1 CDF (Few et al., 2005; Lee et al.,
2002). These CaV2.1 functional changes require CaBP1
N-terminal myristoylation (Few et al., 2005), a modification that
we find irrelevant for CaBP1 modulation of CaV1.2. This result
is corroborated by the ability of a non-myristoylated CaBP1
splice variant, caldendrin, to block CaV1.2 CDI (Tippens and1628 Structure 18, 1617–1631, December 8, 2010 ª2010 Elsevier Ltda
2
th
o
o
th
C
o
C
e
tw
T
th
c
G
w
h
raAll rights reservedLee, 2007). The mechanistic basis for the
difference between CaV1.2 and CaV2.1
modulation by CaBP1 remains unre-
solved. CDI and CDF in CaV1s and
CaV2s arise from the actions of different
CaM lobes (Dunlap, 2007) that are corre-
lated with different Ca2+/CaM binding
modes on the CaV1 (Van Petegem et al.,
2005) and CaV2 (Kim et al., 2008) IQ
domains (however, for alternative expla-
nations, see Mori et al., 2008). Similar to
Ca2+/CaM (Kim et al., 2008; Van Pete-
gem et al., 2005), we find that both
CaBP1 lobes can bind the IQ domain. It
is tempting to speculate that the differen-
tial effects of CaBP1 on CaV1 and CaV2
CDI and CDF and the differential effects
of the CaM lobes with respect to the
same processes are related. CaBP1lso binds other CaM-binding channel segments (Dick et al.,
008; Ivanina et al., 2000; Lee et al., 1999). It is possible that
e differential effects also require interactions with these or
ther channel domains. Delineating how CaBPs act should not
nly unravel CaBP-specific mechanisms but may help dissect
e still imperfectly understood action of CaM with respect to
DI and CDF. Our data provide the framework for investigation
f these issues.
We have identified the features that allow CaBP1 to modulate
aV1.2 differently fromCaM. Our studies reveal an unanticipated
ssential role for the interlobe linker and show that CaBP1 has
o structural modules that encode two separate functions.
he CaBP1 C-lobe serves as the IQ domain anchor, whereas
e N-lobe/linker module contains the elements required for
hannel modulation. The elements comprising the N-lobe/
lu94 interaction are conserved in many CaBPs that interact
ith diverse targets. Thus, the structural underpinnings outlined
ere are likely to aid understanding how CaBPs act on a wide
nge of targets that have dual modulation by CaM and CaBPs.
Figure 8. Comparison of CaBP1-Mediated
and CaM-Mediated CaV1.2 CDF
(A) Relative current changes between the last and
first pulse in response to 40 +20 mV pulses deliv-
ered at 3 Hz for CaV1.2 and CaV1.2 mutants ex-
pressed with indicated CaVb2a, CaBP1, and CaM
combinations.
(B) Averaged frequency-dependent change of ICa
amplitude for (A).
(C) Representative normalized ICa traces at a test
potential of +20 mV for CaV1.2 with CaVb2a and
CaBP1 (orange) or CaM (blue) and CaV1.2 TripleA
(gray) expressed with CaVb2a and CaBP1. Paren-
theses indicate the number of oocytes tested.
Error bars show SD.
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Expression and Purification
Individual human CaBP1-S (AF169148) lobes were expressed as fusion
proteins from a pET28 vector denoted ‘‘HMT’’ (Van Petegem et al., 2004) in
E. coli BL21(DE3)pLysS. CaBP1(D2–15), CaBP1(D2–15) K130A, and selenium
methionine-substituted CaBP1(D2–15) K130A were expressed from a pEGST
vector in E. coli BL21(DE3)pLysS. CaV1.2 IQ domains were made as described
previously (Van Petegem et al., 2005). Expression and purification details can
be found in Supplemental Experimental Procedures.
Crystallization and Refinement
CaBP1(D2–15) was crystallized by hanging drop vapor diffusion at 20C from
equal volumes of protein in buffer A and well solution containing 1.9 M
(NH4)2SO4, 2%–4% 1,2-propanediol, and 0.1 M citrate/sodium citrate (pH
5.5). Native and selenomethionine-substituted CaBP1(D2–15) K130A was
crystallized similarly except that 1,2-propanediol was replaced by 5%–7%
1,6-hexanediol. Crystals were flash frozen in well solution plus 20% glycerol.
Diffraction data were collected at Beamline 8.3.1 (Advanced Light Source,
Lawrence Berkeley National Laboratories) and processed using MOSFLM
7.0.4 (Leslie, 1992). A three-wavelength MAD experiment was performed on
crystals of SeMet-substituted CaBP1(D2–15) K130A. A total of 64 initial sele-
nium positions was located using SHELXD (Uson and Sheldrick, 1999). After
phasing and density modification using DM, the resulting electron density al-
lowed building of an initial model that was improved by iterative cycles of
manual building and refinement against native data using Refmac5 (Collabora-
tive Computational Project, 1994). TLS tensors were used throughout refine-
ment. Tight NCS restraints were employed initially and relaxed in later refine-
ment cycles. Each final model consists of six CaBP1 monomers.
ITC
Titrations were performed at 15C or 25C using a VP-ITC Microcalorimeter
(MicroCal). Samples were dialyzed overnight at 4C (Slide-A-Lyzer, 3.5 kDaStructure 18, 1617–1631, December 8, 2010 ªmolecular weight cutoff; Thermo Scientific)
against 5 mM KCl, 1 mM CaCl2, and 10 mM
HEPES (pH 7.4). After centrifugation (300,
70,000 3 g, 4C), protein concentrations were
determined by absorbance at 280 nm (Edelhoch,
1967). All samples were degassed for 50 prior to
loading into the VP-ITC. CaV1.2 IQ domain peptide
at concentrations of 5.5 or 7.5 mM were titrated
with 75 mM CaBP1 constructs using a schedule
of one 4 ml titrant injection followed by 29 injections
of 10 ml. For competition experiments, 7.5 mM
CaV1.2 IQ domain peptide was preincubated
with 50 mM of Ca2+/N-lobeBP and titrated with
a solution of 75 mMof CaBP1. To correct the base-
line, either heat of dilution from titrations of injec-
tant into buffer was subtracted (Figures 3A and
3D), or the final titration points were used to esti-mate the baseline (Figures 3B and 3F–3H). Data were processed withMicroCal
Origin 7.0 using a single-site binding model or a competitive binding model,
where appropriate.
For binding isotherm analysis of the simultaneous addition of Ca2+/N-lobeBP
and Ca2+/C-lobeBP to the CaV1.2 IQ domain, we used a modified version of
competition ligand binding by displacement ITC (Sigurskjold, 2000) that takes
into account that both ligands are added simultaneously. Thus, the stoichio-
metric concentration of B in the calorimeter cell, Equation (26) from (Sigursk-
jold, 2000), [B]0,i = ft,i[B]0,, is replaced by [B]0,i = [B]s (1ft,i), where [B]s is
concentration of Ca2+/N-lobeBP in the injection syringe, and ft,i is the total
dilution factor after the ith injection, respectively.
Electrophysiology
Human CaV1.2 (a1C77, CAA84346) in pcDNA3.1 (Invitrogen), rat CaVb2a (NP
446303) in pGEMHE, and CaVa2d-1 (NM_00182276) in pcDNA3.1 were co-ex-
pressed with either Homo sapiens CaM (NM_006888) or the short isoform of
human CaBP1-S (AF169148) in pGEMHE for Xenopus oocyte two-electrode
voltage-clamp experiments. Point mutations were introduced using Quik-
Change (Stratagene). For chimera construction, CaM andCaBP1 were divided
into three elements: N-lobe (CaM 1–78 and CaBP1 1–92), linker (CaM 79–82
and CaBP1 93–100 for CaBP1), and C-lobe (CaM 83–149 and CaBP1
101–167). All chimeras having the CaBP1 N-lobe include the N-terminal
myristoylation domain. Inter-element junctions were framed by introduction
of EcoRV sites generated using QuikChange. Elements were excised using
EcoRV and either HindIII or XhoI present in the parent vector and combined
to produce the chimeras. Following chimera generation, junction sites were re-
turned to the native sequence using QuikChange.
After overnight linearization (XhoI for pcDNA3.1 andNheI for pGEMHE), cap-
ped mRNAs were synthesized (T7 mMessenger kit; Ambion) according to the
manufacturer’s protocols. RNA concentrations were determined by A260nm. A
total of 50 nl of CaVa1, CaVb, CaVa2d-1, and CaBP1 or CaM mRNA at a molar
ratio of 1:1:1:20 was injected into defolliculated stage VI Xenopus oocytes
using Nanoject II injector (Drummond Scientific). Oocytes were kept at 18C2010 Elsevier Ltd All rights reserved 1629
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CaBP1 Modulation of CaV1.2in ND96 medium containing penicillin and streptomycin. Two-electrode
voltage-clamp experiments were performed 2–4 days postinjection using
a GeneClamp 500B (Axon Instruments) amplifier controlled by a 1200 MHz
processor computer (Celeron, Gateway) running CLAMPEX 8.2.0.244, and
digitized at 1kHz with a Digidata 1332A (Axon Instruments). Immediately prior
to recording, oocytes were injected with 47 nl of 100 mM BAPTA to minimize
Ca2+-activated Cl current. Recording solutions contained either 40 mM Ba
(OH)2 or 40 mM Ca(NO3)2, 50 mM NaOH, 1 mM KOH, and 10 mM HEPES,
adjusted to pH 7.4 using HNO3. Electrodes were filled with 3 M KCl and had
0.3–2.0 MU resistances. Leak currents were subtracted using a P/4 protocol.
Currents were analyzed with Clampfit 8.2 (Axon Instruments). Oocytes were
superfused during recording using a Valvelink 16 controller (Automate Scien-
tific). Holding potential for all experiments was 90 mV. Results are from at
least two independent oocyte batches. ti300 values were calculated from
normalized currents at +20 mV and represent the percent inactivation after
300 ms. Inactivation t values were calculated at a test potential of +20 mV
as described (Findeisen and Minor, 2009). CDF was elicited by a train of 40,
50 ms pulses to +20 mV at 3 Hz and calculated as the ratio of the peak current
from the last pulse divided by the first. Recovery from inactivation was
measured by a protocol with two 450 ms pulses to +20 mV separated by vari-
able time intervals. Consecutive sweeps were separated by 30 s.
Pull-Down Experiments
Bacterial pellets from a 50 ml culture of CaBP1, CaBP1 mutants, CaM, or
CaBP1/CaM chimeras co-expressed with HMT-tagged CaV1.2 IQ domain
were resuspended in 1.6 ml lysis buffer (10% sucrose, 150 mM KCl, 5 mM
MgCl2, 1 mM CaCl2, 25 mg/ml DNAaseI, 1 mM PMSF, and 100 mM Tris
[pH 8.8]) and lysed by sonication. A total of 100 ml amylose resin in buffer
AmyA (250 mM KCl, 1 mMCaCl2, and 10 mMHEPES/KOH [pH 7.4]) was incu-
bated with the bacterial lysate for 30min at 4Cwith gentle agitation. After four
washes with 500 ml AmyA, bound material was eluted in 500 ml AmyA contain-
ing 10 mM maltose. Input and eluate fractions were analyzed by SDS-PAGE.
ACCESSION NUMBERS
CaBP1 and CaBP1 K130A coordinates and structure factors are deposited
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